drugset / Trial / NCT00912353

AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects

NCT00912353

Phase 1 Completed 56 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

This is a Phase I, single center, randomized, double-blind, placebo-controlled single ascending oral dose study to assess the safety, tolerability and pharmacokinetics of AZD7268 in healthy Japanese subjects.

Timeline

Start
2009-05
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7268 Small molecule Oral

Indications

No indication recorded.